Publicaciones científicas

Cyclosporin A in the treatment of Eaton-Lambert myasthenic syndrome

01-ene-1996 | Revista: Anales de Medicina Interna

Yuste Ara JR, Beloqui Ruiz O, Artieda Gonzalez-Granda J, Herrero Santos JI, De la Peña Fernandez A, Prieto Valtueña J.
Departamento de Medicina Interna, Universidad de Navarra, Pamplona.


The Lambert-Eaton myasthenic syndrome (LEMS) is a disorder of he cholinergic neurotransmition at the presinaptic terminal of the neuromuscular junction.

Clinically it is characterized by muscular weakness, hyporeflexia and autonomic dysfunction. In this entity thet presence of antibodies against calcium channels impair acetylcholine release.

Whe used cyclosporin-A in a patient with LEMS and this resulted in a complete clinical and neurophysiological recovery after four months of therapy.

CITA DEL ARTÍCULO  An Med Interna. 1996 Jan;13(1):25-6

Nuestros autores

Sede Pamplona
Sede Madrid